Clinical Trial Update: Glutamine Supplementation in Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glutamine supplementation in cystic fibrosis has completed, with investigation of effects on immune function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: Emory University | Conditions: Cystic Fibrosis, Immune Function | Phase 2 | Status: COMPLETED